Sivapriya Marappan - Aurigene Discovery Technologies Limited

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 39 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 3303: Paralogue Selective P300 Degraders Induce Synthetic Lethality in Pre-Clinical Models of CBP-deficient and P300-Dependent Malignancies

Saravanan Thiyagarajan,Chandrasekhar Abbineni,Krishna Chaitanya T,Achala Apte,Iram Khan Iqbal,Naveen Kumar R,Aravind A B,Avinash Kumar, Dabbeeru Madhu Babu, Shwetha, Ankita Manna, Monalisha Mandal, Rituparna Panigrahi,Sivapriya Marappan,Suraj T Gore, Mohamad Fairus, Lim Yang Jin,Subhendu Mukherjee,Girish Daginakatte,Shekar Chelur, Kavitha Nellore,Murali Ramachandra,Susanta Samajdar

Cancer Researchno. 6_Supplement (2024): 3303-3303

引用0浏览0引用

A Highly Selective KIT Inhibitor MOD000001 Suppresses IgE-mediated Mast Cell Activation

Yuki Nakamura,Takeo Urakami,Kayoko Ishimaru,Nguyen Quoc Vuong Tran,Takafumi Shimizu,William Sinko,Taisuke Takahashi,Sivapriya Marappan,Kishore Narayanan,Ramulu Poddutoori,Yoh Terada,Atsuhito Nakao

Journal of Allergy and Clinical Immunology Globalpp.100249, (2024)

引用0浏览0WOS引用

Abstract 6065: Identification and Characterization of Paralogue Selective CBP Degraders for Potential Use in Cancer Therapy

Saravanan Thiyagarajan,Chandrasekhar Abbineni,Krishna T. Chaitanya,Achala Apte,Iram Khan Iqbal,Naveen R. Kumar,A. B. Aravind,Avinash Kumar,A. R. Girish, Aishwarya B. Kamath, Deepak Dattatray Mane, Gouri A. Raj, Reshma Reghu, Subhasmita Mohapatra,Sivapriya Marappan,Suraj T. Gore,Subhendu Mukherjee,Girish Daginakatte,Kavitha Nellore,Shekar Chelur,Murali Ramachandra,Susanta Samajdar

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Identification of MOD000001, A Novel Highly Selective and Orally Available KIT Inhibitor Designed for Treatment of Mast Cell-Associated Disorders

Takeo Urakami,Taisuke Takahashi,Takafumi Shimizu,William Sinko,Yuki Nakamura,Kayoko Ishimaru,Vuong Tran,Ramulu Poddutoori,Kishore Narayanan,Sivapriya Marappan,Atsuhito Nakao,Yoh Terada

Journal of Allergy and Clinical Immunology（2023）

引用0浏览0引用

Supplementary Figures 1-3 from Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors Through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases

Maximilien Murone,Anne Vaslin Chessex,Antoine Attinger,Raghuveer K. Ramachandra, Shankar J. Shetty,Girish Daginakatte, Saumitra Sengupta,Sivapriya Marappan,Samiulla Dhodheri,Stefania Rigotti,Yogeshwar Bachhav,Silvano Brienza, Peter Traxler,Marc Lang,Michel Aguet, Vincent Zoete,Olivier Michielin,Courtney Nicholas, Faye M. Johnson,Murali Ramachandra,Andrès McAllister

openalex（2023）

引用0浏览0引用

Discovery of Potent and Paralog Selective PROTAC Degraders of CBP or P300 Proteins for the Treatment of Various Cancers

Chandrasekhar Abbineni,Saravanan Thiyagarajan,Krishna T. Chaitanya,Achala Apte, Naveen R. Kumar,Avinash Kumar, Dabbeeru Madhu Babu, S. Shwetha, Aishwarya B. Kamath, Monalisha Mandel, Rituparna Panigrahi,Sivapriya Marappan,Subhendu Mukherjee, Kavitha Nellore,Shekar Chelur,Murali Ramachandra,Susanta Samajdar

MOLECULAR CANCER THERAPEUTICSno. 12 (2023)

引用0浏览0引用

Abstract B172: Potent Anti-Tumor Activity of a Selective and Orally Bioavailable Reversible Covalent CDK12 Inhibitor

Leena Khare,Ramulu Poddutoori,Subhendu Mukherjee,Samiulla DS, Devaraja TS,Sivapriya Marappan,Shilpa Nayak,Sasirekha Sivakumar, Lakshmi Kaza,Suraj Tgore,Amit Dhudashiya, Raghavendra NR, Bhargav Gunnepalli,Aravind A B,Amith A, Charamanna KB,Thomas Antony, Kavitha Nellore,Girish Daginakatte,Shekar Chelur,Sanjeev Giri,Murali Ramachandra,Susanta Samajdar

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

引用0浏览0引用

Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance

Tapan K. Maity, Eun Young Kim,Constance M. Cultraro,Abhilash Venugopalan,Leena Khare,Ramulu Poddutoori,Sivapriya Marappan, Samiulla D. Syed,William G. Telford,Susanta Samajdar,Murali Ramachandra,Udayan Guha

Cancersno. 8 (2023): 2263

引用0浏览0引用

Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance

Tapan K Maity,Eun Young Kim,Constance M Cultraro,Abhilash Venugopalan,Leena Khare,Ramulu Poddutoori,Sivapriya Marappan, Samiulla D Syed,William G Telford,Susanta Samajdar,Murali Ramachandra,Udayan Guha

CANCERSno. 8 (2023): 2263-2263

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn